Last reviewed · How we verify
Astragalus Membranaceus — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Astragalus Membranaceus (Astragalus Membranaceus) — China Medical University Hospital.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Astragalus Membranaceus TARGET | Astragalus Membranaceus | China Medical University Hospital | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Astragalus Membranaceus CI watch — RSS
- Astragalus Membranaceus CI watch — Atom
- Astragalus Membranaceus CI watch — JSON
- Astragalus Membranaceus alone — RSS
Cite this brief
Drug Landscape (2026). Astragalus Membranaceus — Competitive Intelligence Brief. https://druglandscape.com/ci/astragalus-membranaceus. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab